Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Safety board recommends continuation of Celsion's phase I/II ThermoDox trial in breast cancer

April 7, 2010

Genta begins confirmatory phase IIb trial of tesetaxel in gastric cancer

April 7, 2010

Preclinical and clinical data support reovirus-based prostate cancer therapy ReoT3D

April 7, 2010

Orally available selective CDK inhibitor AT-9311 discovered

April 7, 2010

Novartis claims new PI3K inhibitors for cancer therapy

April 7, 2010

Swiss researchers claim new guanidinium-modified porphyrins and phthalocyanines

April 7, 2010

ArQule reports phase II data on ARQ-197 in non-small cell lung cancer

April 6, 2010

Auckland Uniservices discovers novel nitrobenzindole prodrugs for treatment of cancer

April 6, 2010

Critical Outcome Technologies reports preclinical data on oral COTI-2 in TNBC model

April 1, 2010

YM BioSciences expands ongoing phase I/II CYT-387 study in myelofibrosis

April 1, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...